Skip to content

Orca Bio

High-precision cell therapy to build a healthy immune system

A stem cell transplant from a compatible donor is often the best hope for patients with leukemia and other cancers. But these treatments often come with long-lasting and even fatal side effects, such as graft-versus-host disease (GvHD). Orca Bio lowers the risk of GvHD by identifying the donor cells with real therapeutic benefits and screening out the rest, providing transplant recipients with a designer immune system.

Explore Companies